You just read:

Eiger BioPharmaceuticals Announces Abstracts and Presentations of Lonafarnib Data in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Meeting

News provided by

Eiger BioPharmaceuticals, Inc.

30 Mar, 2016, 08:00 ET